Global Avanafil Market Growth 2025-2031

October 2025 | 98 pages | ID: GB4324C1E568EN
LP Information

Abstracts

The global Avanafil market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Avanafil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Avanafil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Avanafil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Avanafil players cover VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Avanafil Industry Forecast? looks at past sales and reviews total world Avanafil sales in 2024, providing a comprehensive analysis by region and market sector of projected Avanafil sales for 2025 through 2031. With Avanafil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avanafil industry.

This Insight Report provides a comprehensive analysis of the global Avanafil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avanafil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Avanafil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avanafil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avanafil.

This report presents a comprehensive overview, market shares, and growth opportunities of Avanafil market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 50 mg Avanafil
• 100 mg Avanafil
• 200 mg Avanafil

Segmentation by Application:

• The Young Man
• Middle-Aged Person
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• VIVUS Inc
• Sanofi
• Menarini Group
• Auxilium Pharmaceuticals
• Endo International
• JW Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Avanafil market?
What factors are driving Avanafil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Avanafil market opportunities vary by end market size?
How does Avanafil break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Avanafil Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Avanafil by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Avanafil by Country/Region, 2020, 2024 & 2031
2.2 Avanafil Segment by Type
  2.2.1 50 mg Avanafil
  2.2.2 100 mg Avanafil
  2.2.3 200 mg Avanafil
2.3 Avanafil Sales by Type
  2.3.1 Global Avanafil Sales Market Share by Type (2020-2025)
  2.3.2 Global Avanafil Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Avanafil Sale Price by Type (2020-2025)
2.4 Avanafil Segment by Application
  2.4.1 The Young Man
  2.4.2 Middle-Aged Person
  2.4.3 Others
2.5 Avanafil Sales by Application
  2.5.1 Global Avanafil Sale Market Share by Application (2020-2025)
  2.5.2 Global Avanafil Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Avanafil Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Avanafil Breakdown Data by Company
  3.1.1 Global Avanafil Annual Sales by Company (2020-2025)
  3.1.2 Global Avanafil Sales Market Share by Company (2020-2025)
3.2 Global Avanafil Annual Revenue by Company (2020-2025)
  3.2.1 Global Avanafil Revenue by Company (2020-2025)
  3.2.2 Global Avanafil Revenue Market Share by Company (2020-2025)
3.3 Global Avanafil Sale Price by Company
3.4 Key Manufacturers Avanafil Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Avanafil Product Location Distribution
  3.4.2 Players Avanafil Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR AVANAFIL BY GEOGRAPHIC REGION

4.1 World Historic Avanafil Market Size by Geographic Region (2020-2025)
  4.1.1 Global Avanafil Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Avanafil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Avanafil Market Size by Country/Region (2020-2025)
  4.2.1 Global Avanafil Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Avanafil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Avanafil Sales Growth
4.4 APAC Avanafil Sales Growth
4.5 Europe Avanafil Sales Growth
4.6 Middle East & Africa Avanafil Sales Growth

5 AMERICAS

5.1 Americas Avanafil Sales by Country
  5.1.1 Americas Avanafil Sales by Country (2020-2025)
  5.1.2 Americas Avanafil Revenue by Country (2020-2025)
5.2 Americas Avanafil Sales by Type (2020-2025)
5.3 Americas Avanafil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Avanafil Sales by Region
  6.1.1 APAC Avanafil Sales by Region (2020-2025)
  6.1.2 APAC Avanafil Revenue by Region (2020-2025)
6.2 APAC Avanafil Sales by Type (2020-2025)
6.3 APAC Avanafil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Avanafil by Country
  7.1.1 Europe Avanafil Sales by Country (2020-2025)
  7.1.2 Europe Avanafil Revenue by Country (2020-2025)
7.2 Europe Avanafil Sales by Type (2020-2025)
7.3 Europe Avanafil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Avanafil by Country
  8.1.1 Middle East & Africa Avanafil Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Avanafil Revenue by Country (2020-2025)
8.2 Middle East & Africa Avanafil Sales by Type (2020-2025)
8.3 Middle East & Africa Avanafil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avanafil
10.3 Manufacturing Process Analysis of Avanafil
10.4 Industry Chain Structure of Avanafil

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Avanafil Distributors
11.3 Avanafil Customer

12 WORLD FORECAST REVIEW FOR AVANAFIL BY GEOGRAPHIC REGION

12.1 Global Avanafil Market Size Forecast by Region
  12.1.1 Global Avanafil Forecast by Region (2026-2031)
  12.1.2 Global Avanafil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Avanafil Forecast by Type (2026-2031)
12.7 Global Avanafil Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 VIVUS Inc
  13.1.1 VIVUS Inc Company Information
  13.1.2 VIVUS Inc Avanafil Product Portfolios and Specifications
  13.1.3 VIVUS Inc Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 VIVUS Inc Main Business Overview
  13.1.5 VIVUS Inc Latest Developments
13.2 Sanofi
  13.2.1 Sanofi Company Information
  13.2.2 Sanofi Avanafil Product Portfolios and Specifications
  13.2.3 Sanofi Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Sanofi Main Business Overview
  13.2.5 Sanofi Latest Developments
13.3 Menarini Group
  13.3.1 Menarini Group Company Information
  13.3.2 Menarini Group Avanafil Product Portfolios and Specifications
  13.3.3 Menarini Group Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Menarini Group Main Business Overview
  13.3.5 Menarini Group Latest Developments
13.4 Auxilium Pharmaceuticals
  13.4.1 Auxilium Pharmaceuticals Company Information
  13.4.2 Auxilium Pharmaceuticals Avanafil Product Portfolios and Specifications
  13.4.3 Auxilium Pharmaceuticals Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Auxilium Pharmaceuticals Main Business Overview
  13.4.5 Auxilium Pharmaceuticals Latest Developments
13.5 Endo International
  13.5.1 Endo International Company Information
  13.5.2 Endo International Avanafil Product Portfolios and Specifications
  13.5.3 Endo International Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Endo International Main Business Overview
  13.5.5 Endo International Latest Developments
13.6 JW Pharmaceutical
  13.6.1 JW Pharmaceutical Company Information
  13.6.2 JW Pharmaceutical Avanafil Product Portfolios and Specifications
  13.6.3 JW Pharmaceutical Avanafil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 JW Pharmaceutical Main Business Overview
  13.6.5 JW Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Avanafil Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Avanafil Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 50 mg Avanafil
Table 4. Major Players of 100 mg Avanafil
Table 5. Major Players of 200 mg Avanafil
Table 6. Global Avanafil Sales by Type (2020-2025) & (K MT)
Table 7. Global Avanafil Sales Market Share by Type (2020-2025)
Table 8. Global Avanafil Revenue by Type (2020-2025) & ($ million)
Table 9. Global Avanafil Revenue Market Share by Type (2020-2025)
Table 10. Global Avanafil Sale Price by Type (2020-2025) & (USD/MT)
Table 11. Global Avanafil Sale by Application (2020-2025) & (K MT)
Table 12. Global Avanafil Sale Market Share by Application (2020-2025)
Table 13. Global Avanafil Revenue by Application (2020-2025) & ($ million)
Table 14. Global Avanafil Revenue Market Share by Application (2020-2025)
Table 15. Global Avanafil Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Avanafil Sales by Company (2020-2025) & (K MT)
Table 17. Global Avanafil Sales Market Share by Company (2020-2025)
Table 18. Global Avanafil Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Avanafil Revenue Market Share by Company (2020-2025)
Table 20. Global Avanafil Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Avanafil Producing Area Distribution and Sales Area
Table 22. Players Avanafil Products Offered
Table 23. Avanafil Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Avanafil Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Avanafil Sales Market Share Geographic Region (2020-2025)
Table 28. Global Avanafil Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Avanafil Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Avanafil Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Avanafil Sales Market Share by Country/Region (2020-2025)
Table 32. Global Avanafil Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Avanafil Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Avanafil Sales by Country (2020-2025) & (K MT)
Table 35. Americas Avanafil Sales Market Share by Country (2020-2025)
Table 36. Americas Avanafil Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Avanafil Sales by Type (2020-2025) & (K MT)
Table 38. Americas Avanafil Sales by Application (2020-2025) & (K MT)
Table 39. APAC Avanafil Sales by Region (2020-2025) & (K MT)
Table 40. APAC Avanafil Sales Market Share by Region (2020-2025)
Table 41. APAC Avanafil Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Avanafil Sales by Type (2020-2025) & (K MT)
Table 43. APAC Avanafil Sales by Application (2020-2025) & (K MT)
Table 44. Europe Avanafil Sales by Country (2020-2025) & (K MT)
Table 45. Europe Avanafil Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Avanafil Sales by Type (2020-2025) & (K MT)
Table 47. Europe Avanafil Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Avanafil Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Avanafil Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Avanafil Sales by Type (2020-2025) & (K MT)
Table 51. Middle East & Africa Avanafil Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Avanafil
Table 53. Key Market Challenges & Risks of Avanafil
Table 54. Key Industry Trends of Avanafil
Table 55. Avanafil Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Avanafil Distributors List
Table 58. Avanafil Customer List
Table 59. Global Avanafil Sales Forecast by Region (2026-2031) & (K MT)
Table 60. Global Avanafil Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Avanafil Sales Forecast by Country (2026-2031) & (K MT)
Table 62. Americas Avanafil Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Avanafil Sales Forecast by Region (2026-2031) & (K MT)
Table 64. APAC Avanafil Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Avanafil Sales Forecast by Country (2026-2031) & (K MT)
Table 66. Europe Avanafil Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Avanafil Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Avanafil Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Avanafil Sales Forecast by Type (2026-2031) & (K MT)
Table 70. Global Avanafil Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Avanafil Sales Forecast by Application (2026-2031) & (K MT)
Table 72. Global Avanafil Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. VIVUS Inc Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 74. VIVUS Inc Avanafil Product Portfolios and Specifications
Table 75. VIVUS Inc Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. VIVUS Inc Main Business
Table 77. VIVUS Inc Latest Developments
Table 78. Sanofi Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Avanafil Product Portfolios and Specifications
Table 80. Sanofi Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Menarini Group Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 84. Menarini Group Avanafil Product Portfolios and Specifications
Table 85. Menarini Group Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Menarini Group Main Business
Table 87. Menarini Group Latest Developments
Table 88. Auxilium Pharmaceuticals Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 89. Auxilium Pharmaceuticals Avanafil Product Portfolios and Specifications
Table 90. Auxilium Pharmaceuticals Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Auxilium Pharmaceuticals Main Business
Table 92. Auxilium Pharmaceuticals Latest Developments
Table 93. Endo International Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 94. Endo International Avanafil Product Portfolios and Specifications
Table 95. Endo International Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Endo International Main Business
Table 97. Endo International Latest Developments
Table 98. JW Pharmaceutical Basic Information, Avanafil Manufacturing Base, Sales Area and Its Competitors
Table 99. JW Pharmaceutical Avanafil Product Portfolios and Specifications
Table 100. JW Pharmaceutical Avanafil Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. JW Pharmaceutical Main Business
Table 102. JW Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Avanafil
Figure 2. Avanafil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avanafil Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Avanafil Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Avanafil Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Avanafil Sales Market Share by Country/Region (2024)
Figure 10. Avanafil Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 50 mg Avanafil
Figure 12. Product Picture of 100 mg Avanafil
Figure 13. Product Picture of 200 mg Avanafil
Figure 14. Global Avanafil Sales Market Share by Type in 2025
Figure 15. Global Avanafil Revenue Market Share by Type (2020-2025)
Figure 16. Avanafil Consumed in The Young Man
Figure 17. Global Avanafil Market: The Young Man (2020-2025) & (K MT)
Figure 18. Avanafil Consumed in Middle-Aged Person
Figure 19. Global Avanafil Market: Middle-Aged Person (2020-2025) & (K MT)
Figure 20. Avanafil Consumed in Others
Figure 21. Global Avanafil Market: Others (2020-2025) & (K MT)
Figure 22. Global Avanafil Sale Market Share by Application (2024)
Figure 23. Global Avanafil Revenue Market Share by Application in 2025
Figure 24. Avanafil Sales by Company in 2025 (K MT)
Figure 25. Global Avanafil Sales Market Share by Company in 2025
Figure 26. Avanafil Revenue by Company in 2025 ($ millions)
Figure 27. Global Avanafil Revenue Market Share by Company in 2025
Figure 28. Global Avanafil Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Avanafil Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Avanafil Sales 2020-2025 (K MT)
Figure 31. Americas Avanafil Revenue 2020-2025 ($ millions)
Figure 32. APAC Avanafil Sales 2020-2025 (K MT)
Figure 33. APAC Avanafil Revenue 2020-2025 ($ millions)
Figure 34. Europe Avanafil Sales 2020-2025 (K MT)
Figure 35. Europe Avanafil Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Avanafil Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa Avanafil Revenue 2020-2025 ($ millions)
Figure 38. Americas Avanafil Sales Market Share by Country in 2025
Figure 39. Americas Avanafil Revenue Market Share by Country (2020-2025)
Figure 40. Americas Avanafil Sales Market Share by Type (2020-2025)
Figure 41. Americas Avanafil Sales Market Share by Application (2020-2025)
Figure 42. United States Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Avanafil Sales Market Share by Region in 2025
Figure 47. APAC Avanafil Revenue Market Share by Region (2020-2025)
Figure 48. APAC Avanafil Sales Market Share by Type (2020-2025)
Figure 49. APAC Avanafil Sales Market Share by Application (2020-2025)
Figure 50. China Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 54. India Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Avanafil Sales Market Share by Country in 2025
Figure 58. Europe Avanafil Revenue Market Share by Country (2020-2025)
Figure 59. Europe Avanafil Sales Market Share by Type (2020-2025)
Figure 60. Europe Avanafil Sales Market Share by Application (2020-2025)
Figure 61. Germany Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 62. France Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Avanafil Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Avanafil Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Avanafil Sales Market Share by Application (2020-2025)
Figure 69. Egypt Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Avanafil Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Avanafil in 2025
Figure 75. Manufacturing Process Analysis of Avanafil
Figure 76. Industry Chain Structure of Avanafil
Figure 77. Channels of Distribution
Figure 78. Global Avanafil Sales Market Forecast by Region (2026-2031)
Figure 79. Global Avanafil Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Avanafil Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Avanafil Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Avanafil Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Avanafil Revenue Market Share Forecast by Application (2026-2031)